Archive

Eli Lilly 2026 Guidance Signals Momentum In Obesity Care

Eli Lilly has forecast 2026 profit and revenue above Wall Street expectations, reinforcing how fast the obesity market is reshaping Big Pharma growth plans. The recent Eli Lilly 2026 Guidance reflects the company’s confidence in strong future performance. The company also beat estimates for fourth-quarter earnings, helped by strong demand for its injectable weight-loss and […]

Read More

Lenacapavir HIV Prevention Injection to Reach Too Few

South Africa’s first consignment of lenacapavir, a six-monthly HIV prevention injection for high-risk HIV-negative people, will cover fewer than a quarter of the target population. Deliveries are underway and will continue through April. Rollout will begin immediately after delivery, with an initial two-year implementation plan.

Read More

Perinatal Mental Health: Risks and Solutions in Pregnancy

As National Pregnancy Week runs from 3-7 February, the South African Society of Psychiatrists (Sasop) is calling on healthcare providers and expectant mothers to treat perinatal mental health symptoms in pregnancy as urgent medical issues. The society says between 16% and 50% of women in South Africa experience depression or anxiety during pregnancy. It adds […]

Read More

Healthcare Investment Drives Growth and Productivity

Discover how healthcare investment drives growth, linking public health to stronger GDP performance in emerging markets.

Read More

Barrs Pharmaceuticals Secures R92m Hetero Investment

Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure.

Read More

US WHO Withdrawal Official, Organisation Plans Deep Cuts

The US WHO Withdrawal became final in January 2026, raising risks for flu surveillance, outbreak response, and WHO funding as job cuts loom.

Read More

Human HIV Vaccine Trial Begins With BRILLIANT 011

South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.

Read More

Bonitas Tender Dispute: Court Action and Tender Controversy

Get insights into the Bonitas Tender Dispute as Bonitas reacts to Medscheme’s challenge over service provider appointments.

Read More

Bonitas Medscheme Split Sees Momentum and PHA Win Contracts

Bonitas Medscheme split sees Momentum Health and PHA take over key contracts, as a CMS forensic probe and court action continue.

Read More

African Genome Diversity: Wits-Led AGenDA Adds 1,000 Genomes

The African Genome Diversity effort led by Wits adds 1,000+ genomes, improving AI models and precision medicine for African populations.

Read More

Mental Health VAT Reform: Cost Trap Deepens Care Gap

South Africans are reporting rising levels of depression and anxiety. Yet access to care is tightening. High out-of-pocket costs and an entrenched shortage of mental health professionals are leaving many people underserved. In particular, those with the greatest need are most affected.

Read More

Road Accident Fund Insolvency has Deep Roots, Scopa Told

Understand the longstanding insolvency of the Road Accident Fund and the factors contributing to its financial distress.

Read More